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Long-Term Prognosis
of Patients With Peripheral Arterial Disease
A Comparison in Patients With Coronary Artery Disease
Gijs M. J. M. Welten, MD,* Olaf Schouten, MD,* Sanne E. Hoeks, MSC,† Michel Chonchol, MD,§
Radosav Vidakovic, MD,* Ron T. van Domburg, PHD,† Jeroen J. Bax, MD,
Marc R. H. M. van Sambeek, MD,* Don Poldermans, MD‡
Rotterdam and Leiden, the Netherlands; and Denver, Colorado
Objectives This study was designed to compare the long-term outcomes of patients with peripheral arterial disease (PAD)
with a risk factor matched population of coronary artery disease (CAD) patients, but without PAD.
Background The PAD is considered to be a risk factor for adverse late outcome.
Methods A total of 2,730 PAD patients undergoing vascular surgery were categorized into groups: 1) carotid endarterec-
tomy (n  560); 2) elective abdominal aortic surgery (AAA) (n  923); 3) acute AAA surgery (r-AAA) (n  200),
and 4) lower limb reconstruction procedures (n  1,047). All patients were matched using the propensity score,
with 2,730 CAD patients who underwent coronary angioplasty. Survival status of all patients was obtained. In
addition, the cause of death and complications after surgery in PAD patients were noted. The Kaplan-Meier
method was used to compare survival between the matched PAD and CAD population and the different opera-
tion groups. Prognostic risk factors and perioperative complications were identified with the Cox proportional
hazards regression model.
Results The PAD patients had a worse long-term prognosis (hazard ratio 2.40, 95% confidence interval 2.18 to 2.65) and re-
ceived less medication (beta-blockers, statins, angiotensin-converting enzyme inhibitors, aspirin, nitrates, and calcium
antagonists) than CAD patients did (p 0.001). Cerebro-cardiovascular complications were the major cause of long-
term death (46%). Importantly, no significant difference in long-term survival was observed between the AAA and
lower limb reconstruction groups (log rank p 0.70). After vascular surgery, perioperative cardiac complications were
associated with long-term cardiac death, and noncardiac complications were associated with all-cause death.
Conclusions Long-term prognosis of vascular surgery patients is significantly worse than for patients with CAD. The vascular sur-
gery patients receive less cardiac medication than CAD patients do, and cerebro-cardiovascular events are the major
cause of late death. (J Am Coll Cardiol 2008;51:1588–96) © 2008 by the American College of Cardiology
Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.11.077d
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mtherosclerosis is a systemic disease affecting numerous
ascular beds. In patients with peripheral arterial disease
PAD), coronary artery disease (CAD) has a prevalence of
6% to 71% (1,2). Post-operative and long-term prognosis
fter vascular surgery is predominantly determined by un-
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007, accepted November 27, 2007.erlying CAD (3). Furthermore, cardiac death accounts for
pproximately 40% of 30-day mortality, and the 1-year
ortality has been estimated at 6% to 10% (4–7). To
mprove outcomes of patients with PAD requiring surgery,
ssessment and aggressive therapy of atherosclerotic risk
actors is recommended. Hence, the secondary prevention
or subjects with PAD is similar to the measures for patients
ith CAD (8,9). However, data are scarce about the survival
nd treatment of patients with PAD compared with pa-
ients with CAD.
In addition, long-term outcomes in vascular surgery
atients with PAD are ill-defined and often not considered
n the immediate pre-operative workup. To provide infor-
ation on long-term prognosis after open vascular surgery
epairs among an entire stratum of procedures, it would be
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April 22, 2008:1588–96 Outcomes of PAD and CADmportant to understand the relationship between pre-
perative characteristics and nonfatal perioperative compli-
ations with long-term all-cause mortality and cardiac
vents in a large cohort of patients with PAD. Therefore, in
his analysis, we compared survival and treatment of patients
ith PAD scheduled for open vascular surgery procedures
ith a risk factor matched large cohort of patients with
ocumented severe myocardial ischemia referred for coro-
ary angioplasty in the same clinical setting, without signs
r symptoms of PAD.
ethods
tudy design and patient selection. Between January
993 and June 2006, 2,730 PAD patients underwent major
ascular surgery at the Erasmus Medical Center, Rotter-
am, the Netherlands, and were entered into a computer-
zed database. All patients underwent open surgery and were
ategorized into 4 groups, respectively: 1) carotid endarter-
ctomy (CEA); 2) elective infrarenal abdominal aortic
urgery (AAA); 3) acute infrarenal AAA surgery (r-AAA),
nd 4) lower limb arterial reconstruction procedures (LLR).
he medical ethics committee of the Erasmus Medical
enter was informed about the study protocol, and per
nstitutional practice, no official approval was requested.
peration groups. Patients in the CEA group underwent
n elective reconstruction or desobstruction of the carotid
rtery. The AAA group underwent open infrarenal AAA
epair (aortic-to-aortic or aortic-bifurcation prostheses pro-
edures, removal of infected prostheses, and other opera-
ions of the abdominal aorta). Those with a rupture of the
nfrarenal abdominal aorta were classified as r-AAA. Fi-
ally, patients of the LLR group underwent iliac-femoral,
emoral-popliteal, or femoral-tibial artery bypass proce-
ures; removal of infected prostheses; peripheral desobstruc-
ion; and other elective peripheral arterial surgical recon-
tructions.
ropensity score risk factor matched CAD population.
o compare the risk of underlying vascular disease (PAD
r CAD) on long-term mortality, we compared the
ropensity Score Risk Factor Matched PAD and CAD Population
Table 1 Propensity Score Risk Factor Matched PAD and CAD P
Baseline Risk Factors (%)
Before Matching
PAD
(n  2,730)
CAD
(n  15,993)
Age, yrs ( SD) 66 (11) 61 (13)
Males 75 72
Hypertension 45 33
Diabetes mellitus 15 11
Smoking 23 24
Prior PCI 10 11
Prior CABG 19 27
Prior MI 25 38Matched for age, gender, year of operation, hypertension, diabetes mellitus, smoking status, and prior P
CABG  coronary artery bypass graft; CAD  coronary artery disease; MI  myocardial infarction; PADrognosis of patients undergoing
ascular surgery (PAD patients)
ith the survival of a separate
roup of 15,993 patients diag-
osed with severe myocardial
schemia (CAD patients), who
ere referred to the Erasmus
edical Center in the same pe-
iod (1993 to 2006) for coronary
ngioplasty without signs or
ymptoms of PAD obtained
rom review of medical records.
ecause of the differences in
aseline characteristics between
he PAD and CAD populations,
ropensity score methodology
as used to identify comparable
atients with the same risk. First,
propensity score for each pa-
ient was constructed, providing
n estimate of the propensity toward belonging to 1 patient
roup versus the other using multivariate logistic regression
ith the type of population as end point (PAD coded as 0,
AD coded as 1). Included in the analysis were the
ollowing available cardiovascular risk factors: age, gender,
ear of operation, hypertension, diabetes mellitus, smoking
tatus, prior percutaneous coronary intervention, prior cor-
nary artery bypass graft, and prior myocardial infarction
MI). Then, each PAD patient was matched with 1 CAD
atient with the same propensity score, rounded off at 2
eciles. The graphical method of examination by box plots
howed a balance of the estimated propensity score between
AD and CAD patients within each decile of the propen-
ity score. As a result, the matched CAD population
esembled the PAD cohort after matching for cardiovascu-
ar risk factors (Table 1). Finally, a total of 2,730 PAD
atients were matched with 2,730 CAD patients.
In addition, medication use (statins, beta-blockers,
ngiotensin-converting enzyme inhibitors (ACE inhibi-
ors), aspirin, nitrates, and calcium antagonists) of the CAD
Abbreviations
and Acronyms
AAA  elective infrarenal
abdominal aortic surgery
ACE  angiotensin-
converting enzyme
CAD  coronary artery
disease
CCV  cerebro-
cardiovascular
CEA  carotid
endarterectomy
LLR  lower limb arterial
reconstruction procedures
MI  myocardial infarction
PAD  peripheral arterial
disease
r-AAA  acute infrarenal
abdominal aortic surgery
ation
After Matching*
p Value
PAD
(n  2,730)
CAD
(n  2,730) p Value
0.001 66 (11) 66 (12) 1.0
0.001 75 75 1.0
0.001 44 45 0.9
0.001 14 12 0.8
0.008 23 21 0.8
0.02 10 11 0.9
0.001 19 22 0.4
0.001 25 25 1.0CI.
 peripheral arterial disease; PCI  percutaneous coronopulary intervention.
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Outcomes of PAD and CAD April 22, 2008:1588–96opulation was recorded to attempt to explain differences in
urvival between the PAD and CAD populations.
atients’ characteristics. For all PAD patients, we re-
orded age, gender, hypertension (defined as systolic blood
ressure 140 mm Hg, diastolic blood pressure 90 mm
g, and/or use of antihypertensive medication), diabetes
ellitus (the presence of a fasting blood glucose 140
g/dl or requirement for insulin or oral hypoglycemic
gents), smoking status, hypercholesterolemia (total choles-
erol of 200 mg/dl and/or the requirement of lipid-
owering medication), chronic obstructive pulmonary dis-
ase according to symptoms and pulmonary function tests
i.e., forced expiratory volume in 1 s 70% of maximal age
nd gender predictive value), body mass index, renal dys-
unction (baseline serum creatinine 1.5 mg/dl), the pres-
nce of ischemic heart disease (prior MI, prior coronary
evascularization (coronary artery bypass graft or percutane-
us coronary intervention) and angina pectoris), heart fail-
re (defined according the New York Heart Association
unctional classification), and medication (statins, diuretics,
CE inhibitors, calcium antagonists, nitrates, beta-
lockers, aspirin, and anticoagulants). All prescription and
ver-the-counter medications were noted on the day of
dmission.
linical follow-up and end points. Post-operative clinical
nformation was retrieved from an electronic database of
aseline Characteristics of All Patients With PAD, According to Ty
Table 2 Baseline Characteristics of All Patients With PAD, Acc
All Patients
n  2,730 (100%)
CEA
n  560 (21%)
Demographics
Mean age ( SD) 66 (11) 65 (10)
Male (%) 75 73
Cardiovascular risk factor (%)
Body mass index ( SD) 25.0 (5) 25.8 (3)
Current smoker 24 11
Hypertension 45 34
Diabetes mellitus 15 10
Hypercholesterolemia 29 28
COPD 18 7
Renal dysfunction* 12 5
Disease history (%)
Angina 15 7
MI 24 9
Coronary revascularization 24 19
Heart failure 5 1
Medication use (%)
Statins 26 26
Diuretics 18 10
ACE inhibitors 31 21
Calcium antagonists 34 27
Nitrates 19 13
Beta-blockers 33 26
Aspirin 40 73
Anticoagulation 20 6
Baseline serum creatinine 1.5 mg/dl.
AAA  elective infrarenal abdominal aortic surgery; ACE  angiotensin-converting enzyme; CEA  car
econstruction procedures; r-AAA  acute infrarenal abdominal aortic surgery; other abbreviations as in Tatients followed in our hospital. On occasion, missing data
ere abstracted retrospectively by reviewing patients’ medical
ecords. Routinely, all vascular surgery patients are screened for
dverse post-operative outcome by repeated cardiac isoenzyme
easurements and electrocardiographic recording. Additional
ests are performed at the discretion of the attending physician.
fter surgery, patients visit the outpatient clinic regularly and
re screened for late cardiac events. From the municipal civil
egistries, we obtained the survival status. At the reference date,
anuary 2007, follow-up was complete in 99.3% of cases. The
ean follow-up of the PAD patients was 6.37  4.08 years,
he mean follow-up of the CAD patients was 9.17  4.14
ears. The primary end point was long-term all-cause mortality
n the PAD and CAD populations. The secondary end point
as the composite of perioperative mortality and nonfatal
vents in the PAD population.
erioperative and long-term mortality. Perioperative all-
ause mortality was defined as death occurring during 30-day
n-hospital stay or as death occurring after hospital discharge
ut within the first 30 days after surgery. Cardiac death was
efined as death secondary to MI, heart failure, or arrhythmias.
ong-term all-cause mortality was defined as death beyond 30
ays after surgery; deaths that occurred in the 30-day period
ere thus excluded from the long-term period.
The cause of death in the PAD population was grouped
nto a cerebro-cardiovascular (CCV), a non-CCV, and an
Operation
g to Type of Operation
AAA
n  923 (34%)
r-AAA
n  100 (7%)
LLR
n  1,047 (38%) p Value
66 (11) 71 (9) 65 (12) 0.001
78 88 72 0.001
24.9 (5) 25.4 (3) 24.7 (4) 0.006
28 14 29 0.001
53 43 46 0.001
13 10 20 0.001
37 33 26 0.001
26 20 17 0.001
13 20 14 0.001
17 14 19 0.001
30 27 31 0.01
26 20 28 0.001
6 5 7 0.001
33 19 23 0.001
18 19 23 0.001
35 25 34 0.001
43 22 32 0.001
21 14 20 0.001
45 22 29 0.001
33 28 32 0.001
17 10 33 0.001pe of
ordinotid endarterectomy; COPD  chronic obstructive pulmonary disease; LLR  lower limb arterial
able 1.
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April 22, 2008:1588–96 Outcomes of PAD and CADnknown cause of death. A CCV death was defined as any
eath with a cerebro-cardiovascular complication as the
rimary or secondary cause and included deaths following
I, serious cardiac arrhythmias (defined as the presence of
sustained cardiac rhythm disturbance that required urgent
edical intervention), congestive heart failure, stroke (cere-
rovascular accident or transient ischemic attack), surgery-
elated bleeding complications (only a post-operative cause
f death), and others. Sudden unexpected death was classi-
ed as a CCV death. An MI was defined as the presence of
out of the following 3 criteria: 1) typical chest pain
omplaints; 2) electrocardiographic changes including acute
T-segment elevation followed by appearance of Q waves or
oss of R waves, or new left bundle branch block, or new
ersistent T wave inversion for at least 24 h, or new
T-segment depression that persisted 24 h; and 3) a
ositive troponin T (i.e., 0.10 ng/ml) or peak creatinine
hosphokinase myocardial band 8% of an elevated total
reatinine phosphokinase with characteristic rise and fall
10). Non-CCV death was defined as any death with a
rincipal non-CCV cause, including infection, malignancy,
espiratory insufficiency, and others. The cause of death was
scertained by reviewing medical records, the computerized
ospital database, autopsy reports, or by contacting the
eferring physician or general practitioner.
onfatal perioperative events in the PAD population.
e recorded the following nonfatal complications within
0 days after surgery: infection (such as wound infection,
neumonia, sepsis, and urinary tract infection), MI, ar-
hythmias, heart failure, stroke, reoperation (percutaneous
evascularization or bypass surgery to a vessel that has been
reated during the index procedure), hemorrhage (arterial
leeding leading to hypotension (systolic pressure of 100
m Hg) requiring blood transfusion), thrombectomy, am-
utation (excluded toe amputation), perioperative renal
ysfunction (peak post-operative serum creatinine 0.5
g/dl within 3 days after surgery compared with pre-
perative serum creatinine), and the requirement of hemo-
ialysis (excluding pre-operative hemodialysis).
tatistical analysis. Continuous data are described as mean
alues and standard deviations, and dichotomous data are
escribed as percentage frequencies. The chi-square test was
sed for categorical variables, and the analysis of variance
est was used for continuous variables.
Kaplan-Meier survival analysis was used to compare
urvival times between the PAD and CAD patients and the
PAD subgroups, stratified by type of surgery. To test for
ifferences between the resulting curves, the log-rank test
as used. For the long-term survival analysis using the
aplan-Meier method, we included those who died within
0 days after surgery.
A univariate Cox proportional hazard regression model
as used to explore the association of underlying vascular
isease on long-term survival. We used univariate and not
ultivariate analysis because we matched all PAD andAD patients for the available baseline cardiovascular risk
actors. For this long-term analysis, we included all survivors
ithin 30 days after vascular surgery.
Multivariate logistic regression and Cox proportional
azard regression models were used to explore the relation-
hip of major baseline risk factors of all PAD patients
ndergoing vascular surgery and perioperative all-cause and
ardiac death, respectively. Risk factors entered in the risk
odel were type of operation, age 70 years, gender,
hronic obstructive pulmonary disease, hypertension, diabe-
es mellitus, smoking status, hypercholesterolemia, prior
I, prior heart failure, prior coronary revascularization,
rior angina, and renal dysfunction. For the long-term
ll-cause and cardiac mortality, multivariate Cox propor-
ional hazards regression analysis was performed and in-
luded also all nonfatal perioperative complications.
All univariate risk factors with a p value of 0.10 were
ntered in the perioperative and long-term multivariate
nalysis, resulting in an adjusted significant odds and hazard
atios (ORs and HRs) or as not significant. Unadjusted and
djusted ORs and HRs were reported with corresponding
5% confidence intervals (CIs). A p value of 0.05 was
onsidered to be significant. All computations were per-
ormed with SPSS software version 12.0.1 (SPSS Inc.,
hicago, Illinois), running under Windows 2000 Profes-
ional (Microsoft, Redmond, Washington).
Figure 1 Kaplan-Meier Estimate of Long-Term Survival of CAD
and Different Types of Peripheral Surgical Patients
To test for differences between the resulting curves, the log-rank test was
used. AAA  elective infrarenal abdominal aortic surgery; CAD  coronary
artery disease; CEA  carotid endarterectomy; LLR  lower limb arterial recon-
struction; r-AAA  acute infrarenal AAA.
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Outcomes of PAD and CAD April 22, 2008:1588–96esults
atient characteristics. The mean age of all patients with
AD (n  2,730) was 64  16 years and 76% were male. A
otal of 560 patients (20%) underwent CEA surgery; 923
Figure 2 Medication Use According to PAD and CAD Patients
ACE  angiotensin-converting enzyme;
PAD  peripheral arterial disease; other abbreviation as in Figure 1.
ause of Death During the Perioperative and Long-Term Period
Table 3 Cause of Death During the Perioperative and Long-Term
All Patients
n  2,730 (100%)
CEA
n  560 (21%)
Perioperative mortality 153 (6) 8 (1)
Total CCV death n (%) 116 (76) 6 (75)
MI 28 (18) 2 (25)
Congestive heart failure 15 (10) 0 (0)
Arrhythmia 15 (10) 0 (0)
Stroke 9 (6) 3 (38)
Fatal bleeding 40 (26) 1 (13)
Other 9 (6) 0 (0)
Total n-CCV death n (%) 37 (24) 2 (25)
Infection 22 (14) 0 (0)
Malignancy 0 (0) 0 (0)
Respiratory insufficiency 9 (6) 2 (25)
Others 6 (4) 0 (0)
Unknown n (%) 0 (0) 0 (0)
Long-term mortality* 1,353 (53) 216 (39)
Total CCV death n (%) 625 (46) 91 (42)
MI 250 (19) 31 (14)
Congestive heart failure 168 (12) 28 (13)
Arrhythmia 26 (2) 2 (1)
Stroke 96 (7) 22 (10)
Others 85 (6) 8 (4)
Total n-CCV death n (%) 412 (31) 66 (31)
Infection 78 (6) 4 (2)
Malignancy 153 (11) 32 (15)
Respiratory insufficiency 85 (6) 9 (4)
Others 96 (7) 21 (10)
Unknown n (%) 316 (23) 59 (27)Excluding those patients who died within the post-operative period (n  153).
CCV  cerebro-cardiovascular; n-CCV  noncerebro-cardiovascular; other abbreviations as in Table 2.atients (34%) underwent AAA surgery (aortic-to-aortic
 206, aortic bifurcation n  624, infected prostheses
 51, and others n  42); 200 patients (7%) had a r-AAA;
nd 1,047 patients (38%) underwent LLR surgery (iliac-
emoral n  208, femoral-popliteal n 6 03, femoral-tibial
 203, and infected prostheses n 33). Patient’s character-
stics are presented in Table 2.
rimary end point. Compared with CAD patients, pa-
ients with PAD had a significantly worse long-term prog-
osis (unadjusted HR 2.40, 95% CI 2.18 to 2.65) (Fig. 1).
nnual mortality rates of the PAD and CAD populations
ere 5.7% and 3.0% per year (p  0.001). Importantly,
atients with CAD received more cardiac medications than
he PAD patients did (beta-blockers 74% vs. 34%, calcium
ntagonists 52% vs. 33%, aspirin 88% vs. 40%, nitrates 37%
s. 19%, statins 67% vs. 29%, and ACE inhibitors 57% vs.
1%, respectively) (Fig. 2).
econdary end point. Within 30 days after surgery, a total of
53 PAD patients (5.6%) died. The overall mortality of the
EA, AAA, r-AAA, and LLR groups was 8 (1.4%), 58
6.3%), 57 (28.5%), and 30 (2.9%) (p  0.001), respectively.
he leading causes of death were CCV events (76%) (Table 3).
pecified according to the type of surgery, the leading cause
f death at 30 days for CEA patients was stroke (38%), for
iod
AAA
n  923 (34%)
r-AAA
n  200 (7%)
LLR
n  1,047 (38%) p Value
58 (6) 57 (29) 30 (3)
45 (78) 46 (81) 19 (63) 0.3
14 (24) 6 (11) 6 (20) 0.3
7 (12) 4 (7) 4 (13) 0.5
4 (7) 7 (12) 4 (13) 0.5
3 (5) 3 (5) 1 (3) 0.001
13 (22) 23 (40) 3 (10) 0.01
5 (9) 3 (5) 1 (3) 0.6
13 (22) 11 (19) 11 (37) 0.3
4 (7) 8 (14) 10 (33) 0.005
0 (0) 0 (0) 0 (0) NA
4 (7) 2 (4) 1 (3) 0.1
5 (9) 1 (2) 0 (0) 0.1
0 (0) 0 (0) 0 (0) NA
470 (54) 87 (61) 580 (57)
203 (43) 36 (41) 295 (51) 0.03
85 (18) 15 (17) 119 (21) 0.2
41 (9) 10 (12) 89 (15) 0.01
11 (2) 3 (3) 10 (2) 0.4
33 (7) 5 (7) 35 (6) 0.2
33 (7) 2 (2) 42 (7) 0.1
150 (32) 30 (35) 166 (29) 0.6
26 (6) 7 (8) 41 (7) 0.03
54 (12) 7 (8) 60 (10) 0.2
31 (7) 10 (12) 35 (6) 0.1
39 (8) 6 (7) 30 (5) 0.09
117 (25) 21 (24) 119 (21) 0.2Per
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April 22, 2008:1588–96 Outcomes of PAD and CADAA was MI (24%), for r-AAA was fatal bleeding (40%),
nd for LLR was infection (40%). Outcomes at 30 days of
atients undergoing CEA or LLR were superior to patients
ndergoing AAA surgery (Fig. 3). Patients scheduled for
-AAA surgery had the worst 30-day outcome. Also, in the
ultivariate Cox proportional hazards regression analysis,
he type of operation was an important independent risk
Figure 3 Kaplan-Meier Estimate of Overall Perioperative (30-
Day) Survival of Different Types of Surgical Patients
To test for differences between the resulting curves,
the log-rank test was used. Abbreviations as in Figure 1.
ultivariate Associations of Baseline Characteristics With All-Caus
Table 4 Multivariate Associations of Baseline Characteristics W
Risk Factor
Perioperative All-Cause Mortali
OR Univariate (95% CI) OR Multiv
Operation group
LLR (reference) 1.0
r-AAA 13.51 (8.40–21.74) 12.22 (
AAA 2.27 (1.45–3.57) 2.00 (
CEA 0.49 (0.22–1.07)
Gender 1.19 (0.80–1.77)
Age 70 yrs 2.31 (1.66–3.21) 1.55 (
Hypertension 1.50 (1.08–2.09) 1.55 (
COPD 2.39 (1.68–3.40) 2.05 (
Diabetes mellitus 1.13 (0.73–1.76)
Hypercholesterolemia 0.71 (0.40–1.23)
Current smoker 1.10 (0.73–1.68)
MI 1.22 (0.80–1.89)
Coronary revascularization 0.54 (0.34–0.84)
Heart failure 1.26 (0.65–2.34)
Angina 1.11 (0.60–2.03)
Renal dysfunction† 2.61 (1.77–3.84) 2.09 (Death because of MI, heart failure, and arrhythmia. †Baseline serum creatinine 1.5 mg/dl.
CI  confidence interval; NS  not significant; OR  odds ratio; other abbreviations as in Table 2.actor for perioperative all-cause mortality and cardiac
vents (Table 4).
A total of 1,353 (52.5%) patients with PAD died during
.37  4.08 years of follow-up, excluding the 153 patients
ho died within 30 days post-operatively. Mortality rates
mong the different surgical procedures were 216 (39.1%),
70 (54.3%), 87 (60.8%), and 580 (57.0%) for CEA, AAA,
-AAA, and LLR, respectively. Annual mortality rates of
EA, AAA, LLR, and r-AAA are 5.0%, 5.9%, 5.9%, and
.8% per year (log rank p  0.001), respectively. The
eading cause of death was CCV (46%). Myocardial infarc-
ion accounts for 19% of all causes of long-term mortality.
uring long-term follow-up, patients of the LLR group
ad a similar prognosis compared with the AAA group (log
ank p  0.70), but patients of the r-AAA group had the
orst outcome (Fig. 1). However, the multivariate Cox
roportional hazards regression analysis illustrated that,
onverse to the perioperative outcome, the type of surgery
as not related to outcome during long-term follow-up
Table 5). The proportional hazards assumptions were
ested by constructing interaction terms between the vari-
bles and time to each end point. The Cox proportional
azards regression analyses showed no statistically signifi-
ant interaction with time (each p value 0.05).
Long-term all-cause outcome was affected by age, smoking,
hronic obstructive pulmonary disease, MI, renal dysfunction,
nd noncardiac complications (infection, stroke, and amputa-
ion). Pre-operative cardiac risk factors (age 70 years, diabe-
es mellitus, prior MI, coronary revascularization, heart failure)
nd perioperative nonfatal cardiac complications (MI, heart
ailure, arrhythmia) were the primary determinants of long-
erm adverse cardiac outcome.
d Cardiac Mortality in the Perioperative Period
All-Cause and Cardiac Mortality in the Perioperative Period
Perioperative Cardiac Death*
(95% CI) OR Univariate (95% CI) OR Multivariate (95% CI)
1.0 1.0
0.04) 6.86 (3.32–14.15) 6.21 (2.94–13.12)
.16) 2.05 (1.06–3.97) 1.89 (1.01–3.68)
0.26 (0.06–1.17) NS
1.40 (0.72–2.72) NS
.21) 2.57 (1.50–4.39) 1.95 (1.12–3.39)
.22) 1.72 (1.02–2.92) NS
.01) 2.06 (1.17–3.62) NS
1.20 (0.60–2.40) NS
0.83 (0.36–1.96) NS
0.88 (0.43–1.81) NS
1.41 (0.80–2.47) NS
0.65 (0.33–1.28) NS
2.50 (1.12–5.61) NS
1.27 (0.55–2.96) NS
.18) 2.88 (1.60–5.19) 2.11 (1.15–3.88)e an
ith
ty
ariate
1.0
7.46–2
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ur main finding of this study is that patients with PAD,
ompared with a matched population for cardiac risk factors
nd year of treatment with CAD, are at increased risk for
ong-term mortality. In addition, PAD patients receive less
ardiovascular medical therapy (e.g., beta-blockers, statins,
CE inhibitors, calcium antagonists, nitrates, and aspirin)
han CAD patients do.
Furthermore, we conclude that CCV death is the major
ause of perioperative and long-term mortality among
ascular surgical patients with PAD (76% and 46%, respec-
ively). Cardiac risk factors and perioperative cardiac com-
lications are associated with long-term cardiac death, but
oncardiac complications including infection, stroke, am-
utation, acute renal failure, and dialysis dependency are
ainly related with all-cause mortality. The type of vascular
urgery was found to be an independent risk factor for an
dverse outcome in the perioperative period but not during
ultivariate Associations of Baseline Characteristics and Nonfataleriope ative Complications With Long-Te m All-Cau e and Cardi c
Table 5 Multivariate Associations of Baseline Characteristics aPerioperative Complications With Long-Term All-Cause
Risk Factor
Long-Term All-Cause Mortali
HR Univariate (95% CI) HR Multi
Baseline risk factors
Operation group
LLR (reference) 1.0
r-AAA 1.29 (1.03–1.62)
AAA 0.97 (0.86–1.09)
CEA 0.66 (0.57–0.78)
Gender 1.15 (1.01–1.30)
Age 70 yrs 2.18 (1.96–2.43) 2.11
Hypertension 1.15 (1.03–1.28)
COPD 1.60 (1.41–1.81) 1.49
Diabetes mellitus 1.32 (1.14–1.52)
Hypercholesterolemia 1.06 (0.93–1.22)
Current smoker 1.30 (1.16–1.46) 1.20
MI 1.43 (1.28–1.62)
Coronary revascularization 1.08 (0.96–1.22)
Heart failure 1.74 (1.41–2.14)
Angina 1.26 (1.10–1.45)
Renal dysfunction† 2.23 (1.83–2.47) 1.72
Post-operative complications
Nonfatal MI 1.45 (1.19–1.76)
Heart failure 2.20 (1.47–3.29)
Arrhythmia 2.04 (1.41–2.98) 1.65
Infection 1.75 (1.52–2.02) 1.51
Stroke 2.05 (1.55–2.72) 1.98
Amputation 2.03 (1.58–2.61) 1.74
Hemorrhage 1.24 (0.99–1.57)
Thrombectomy 1.14 (0.87–1.48)
Reoperation 1.30 (0.98–1.74)
Acute renal failure‡ 1.81 (1.54–2.12) 1.44
Hemodialysis§ 2.95 (1.98–4.38) 1.67
Death because of MI, heart failure, and arrhythmia. †Baseline serum creatinine1.5 mg/dl. ‡Pea
re-operative serum creatinine. §Excluding patients who were on pre-operative dialysis.
HR  hazard ratio; other abbreviations as in Table 2.he long-term follow-up. The long-term prognosis of pa- rients undergoing acute repair of the ruptured abdominal
orta is similar to patients undergoing elective AAA sur-
ery, contrary to the perioperative period. Similar results
ere observed by Soisalon-Soininen et al. (11) among 1,070
atients undergoing repair of ruptured and nonruptured
bdominal aorta aneurysms.
Aggressive treatment of atherosclerotic risk factors (i.e.,
ypertension, diabetes mellitus, smoking, and hypercholes-
erolemia) and usage of cardioprotective medications (i.e.,
eta-blockers, statins, aspirin, and ACE inhibitors) are
ecommended for PAD patients, because they are associated
ith improved long-term survival (12–14). However, in our
atched PAD and CAD population for cardiovascular risk
actors, we clearly observed an underuse of cardiac medica-
ion among patients with PAD. McDermott et al. (8)
eported that patients with CAD, compared with PAD
atients, are treated more frequently with aspirin and
ipid-lowering medication (82% vs. 37% and 56% vs. 40%,
tality
onfatal
Cardiac Mortality
Long-Term Cardiac Death*
(95% CI) HR Univariate (95% CI) HR Multivariate (95% CI)
1.0 1.0
1.11 (0.75–1.64) NS
0.75 (0.61–0.93) NS
0.50 (0.38–0.67) NS
1.13 (0.91–1.41) NS
2.36) 2.00 (1.65–2.41) 2.02 (1.66–2.47)
1.18 (0.98–1.42) NS
1.71) 1.29 (1.02–1.63) NS
1.87 (1.50–2.34) 1.47 (1.16–1.87)
1.38 (1.10–1.72) NS
1.36) 1.44 (1.18–1.76) NS
2.59 (2.15–3.13) 1.59 (1.26–2.01)
2.17 (1.80–2.62) 1.61 (1.30–1.99)
2.94 (2.19–3.94) 1.45 (1.04–2.01)
2.22 (1.81–2.73) 1.21 (1.01–1.59)
2.02) 2.31 (1.80–2.96) 1.60 (1.22–2.09)
4.07 (2.17–7.63) 2.22 (1.15–4.28)
3.36 (1.89–5.96) 1.86 (1.01–3.43)
2.43) 2.41 (1.33–4.40) 1.86 (1.00–3.52)
1.76) 1.51 (1.17–1.96) NS
2.67) 1.57 (0.90–2.73) NS
2.29) 1.50 (0.84–2.68) NS
0.95 (0.60–1.50) NS
1.45 (0.96–2.19) NS
1.49 (0.93–2.39) NS
1.73) 1.73 (1.31–2.29) 1.39 (1.01–1.92)
2.63) 3.13 (1.61–6.06) NS
operative serum creatinine0.5 mg/dl (44 mol/l) within 3 days after surgery compared withMor
nd N
and
ty
variate
1.0
NS
NS
NS
NS
(1.88–
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NS
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April 22, 2008:1588–96 Outcomes of PAD and CADan explain their worse long-term outcome when compared
ith CAD patients.
Peripheral atherosclerotic disease is becoming an increas-
ngly important health issue in Western society; it affects
etween 8 to 12 million adults (15). The introduction of
ndovascular repair has the potential to improve the out-
ome for PAD patients undergoing noncardiac surgery
ecause of its reduced perioperative myocardial stress (16).
his technique is currently considered as a promising
lternative, especially in high-risk cardiac patients. In addi-
ion, new cardioprotective strategies, including medical
herapy (17) and prophylactic coronary interventions (18),
re currently being evaluated in these patients. Though the
reliminary results of endovascular repair are promising and
ssociated with improved immediate post-operative out-
ome, the beneficial effect on long-term survival remains
ontroversial (3,19,20). We described the results of open
urgery in a tertiary hospital in relation to long-term
utcome of patients undergoing different types of vascular
urgery. The results of this study will provide useful infor-
ation to compare long-term outcome between open and
ndovascular surgery.
We do think that propensity matching is appropriate in
his study setting. In this study, we deal with patients with
he same underlying disease, namely generalized atheroscle-
osis. However, patients with PAD present themselves with
ifferent clinical symptoms (e.g., claudication), compared
ith the more cardiac-related complications (e.g., angina)
bserved in CAD patients. We used the propensity score to
ompare survival of patients with generalized atherosclerosis
ith the same risk profile with 2 different treatments (PAD
r CAD).
tudy limitations. First, the study is not a randomized
linical trial but an observational study of a propensity-
atched cohort. Despite using propensity to adjust as
uch as possible for the bias inherent in the decision
bout being PAD or CAD patients, we cannot exclude
he possibility of residual confounding. As can be seen in
able 1, the PAD and CAD populations differed signif-
cantly, and by using the propensity score matching
rocedure, the resulting matched CAD cohort ultimately
eassembled the PAD cohort. We did not match the
AD and CAD database with the risk factor hypercho-
esterolemia, because of the inconsistency of the CAD
atabase regarding the reporting of hypercholesterolemia
uring the early stage of our study period. Second,
lthough data were prospectively collected, this analysis is
etrospective. Because of the acute setting of r-AAA
atients, not all the baseline characteristics were com-
letely recorded in the admission data, which might
esult in an underdiagnosis of some risk factors. Third,
hanges in the perioperative management have evolved
arkedly over time and were not taken into account in
ur analysis. These include multiple factors ranging from
reoperative management, such as drug therapy, to an-
sthesiological and surgical techniques to intensive post-urgical care management. We tried to adjust for this
onfounding by adding the year of operation in our
ultivariate analysis (as a categorical variable per 2
ears). We did not investigate our results across different
ime periods, because we did not observe different peri-
perative (30-day) outcomes in the PAD database over
ime. Finally, in our cohort, we found a remarkably low
ncidence of diabetes mellitus (15%). The diagnosis of
iabetes mellitus was based on the requirement for
nsulin therapy, hypoglycemic agents, or as fasting blood
lucose 140 mg/dl. In patients qualified as nondia-
etics with PAD, fasting glucose levels may be normal,
nd the diagnosis of diabetes is only made after a glu-
ose loading test. Unfortunately, we did not routinely
erform a loading test for patients with a normal fasting
lucose. Therefore, the number of diabetics might be
nderestimated.
eprint requests and correspondence: Prof. Dr. Don Polder-
ans, Department of Anesthesiology, Erasmus MC, Graven-
ijkwal 230, 3015 CE Rotterdam, the Netherlands. E-mail:
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